D.E. Shaw & Co’s Allogene Therapeutics ALLO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.74M Buy
2,763,776
+1,480,805
+115% +$2.97M ﹤0.01% 1959
2025
Q4
$1.76M Buy
1,282,971
+819,073
+177% +$1.08M ﹤0.01% 3151
2025
Q3
$575K Buy
+463,898
New +$553K ﹤0.01% 3795
2025
Q1
Sell
-54,517
Closed -$116K 4223
2024
Q4
$116K Sell
54,517
-35,808
-40% -$88.3K ﹤0.01% 4155
2024
Q3
$253K Sell
90,325
-149,930
-62% -$400K ﹤0.01% 4061
2024
Q2
$560K Buy
240,255
+44,477
+23% +$131K ﹤0.01% 3558
2024
Q1
$875K Buy
195,778
+120,138
+159% +$501K ﹤0.01% 3177
2023
Q4
$243K Sell
75,640
-48,598
-39% -$138K ﹤0.01% 3819
2023
Q3
$394K Sell
124,238
-151,610
-55% -$664K ﹤0.01% 3516
2023
Q2
$1.37M Sell
275,848
-236,828
-46% -$1.28M ﹤0.01% 2899
2023
Q1
$2.53M Sell
512,676
-147,511
-22% -$946K ﹤0.01% 2506
2022
Q4
$4.15M Buy
660,187
+220,492
+50% +$2.04M ﹤0.01% 2266
2022
Q3
$4.75M Buy
439,695
+156,004
+55% +$2.12M 0.01% 2155
2022
Q2
$3.23M Sell
283,691
-701,412
-71% -$6.23M ﹤0.01% 2632
2022
Q1
$8.97M Buy
985,103
+455,288
+86% +$4.74M 0.01% 1697
2021
Q4
$7.91M Buy
529,815
+507,107
+2,233% +$8.95M 0.01% 1902
2021
Q3
$584K Sell
22,708
-179,555
-89% -$4.26M ﹤0.01% 3993
2021
Q2
$5.28M Buy
+202,263
New +$5.77M ﹤0.01% 1982
2020
Q4
Sell
-6,459
Closed -$244K 3887
2020
Q3
$244K Buy
+6,459
New +$244K ﹤0.01% 3543
2020
Q1
Sell
-125,030
Closed -$3.25M 3893
2019
Q4
$3.25M Buy
+125,030
New +$3.44M ﹤0.01% 2086

Other funds holding ALLO